Age contrasts in patients with advanced epithelial ovarian cancer: The M. D. Anderson cancer center experience

Background. This study reviews the experience at the University of Texas M. D. Anderson Cancer Center with elderly patients treated for advanced epithelial ovarian cancer with cisplatin-based combination chemotherapy. Methods. From 1978 through 1988, 215 patients with Stage III or IV, Grade 2 or 3 epithelial ovarian cancer were entered onto one of three consecutive trials involving cisplatin-based combination chemotherapy